SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Shionogi Study Links Edaravone to Improved Progression-Free Survival in ALS

A Shionogi study links edaravone to improved progression-free survival in patients with ALS.

Related stories